학술논문
Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up)
Document Type
Article
Author
Source
In The Breast 2011 20(2):155-157
Subject
Language
ISSN
0960-9776